| NCT Number | NCT07024147 |
| Lead Sponsor | Peking University Cancer Hospital & Institute
Collaborators: Shanghai JW Therapeutics Co., Ltd. |
| Conditions | B-Cell Non-Hodgkin Lymphoma, Large B Cell Diffuse Lymphoma, Follicular Lymphoma, Marginal Zone B Cell Lymphoma, Mantle Cell Lymphoma (MCL) |
| Enrollment | 20 participants |
| Start Date | 2025-07-01 |
| Primary Completion | 2027-07-01 (estimated) |
| Study Completion | 2030-07-01 (estimated) |
| Updated on ClinicalTrials.gov | 2025-06-17 |